NCT04409457

Brief Summary

This study examines the influence of acute fasting and eating on self-control in adult females with and without bulimia nervosa (BN). Specifically, the study team is investigating whether differences in behavior and brain activation in response to computer tasks after fasting and after eating a meal could help to explain the symptoms of bulimia nervosa. Data will be collected using questionnaires and a technology called magnetic resonance imaging (MRI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 1, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

September 18, 2020

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 14, 2026

Completed
Last Updated

February 6, 2026

Status Verified

November 1, 2025

Enrollment Period

4.1 years

First QC Date

May 18, 2020

Results QC Date

November 5, 2025

Last Update Submit

January 21, 2026

Conditions

Keywords

bulimia nervosabinge eatingpurgingfastingeating disordercontrol

Outcome Measures

Primary Outcomes (4)

  • Brain Activation Associated With P(Stop)

    Frontostriatal activation modulated by the predicted need for inhibition (P(stop) (i.e., parametric modulation by p(Stop)), measured as the mean BOLD signal across voxels within the region of interest (ROI). Positive values indicate that neural activation increases as the predicted probability of needing to stop increases (i.e., stronger responses when stopping is predicted to be more likely), whereas negative values indicate that activation decreases as the predicted probability of needing to stop increases (i.e., greater activation when stopping is predicted to be less likely).

    after 16 hours of fasting and at 30 minutes after a standardized meal (as least 24 hours apart, but not more than 7 days apart)

  • Brain Activation Associated With Prediction Errors (Unsigned)

    Frontostriatal activation modulated by unsigned inhibitory control prediction errors (i.e., parametric modulation by absolute prediction error magnitude), measured as the mean BOLD signal across voxels within the region of interest (ROI). Positive values indicate that neural activation increases with the magnitude of unsigned prediction errors (i.e., stronger responses to more surprising outcomes), whereas negative values indicate that activation decreases as unsigned prediction errors increase (i.e., relative deactivation for more surprising outcomes).

    after 16 hours of fasting and at 30 minutes after a standardized meal (as least 24 hours apart, but not more than 7 days apart)

  • Brain Activation Associated With Prediction Errors (Signed)

    Frontostriatal activation modulated by signed inhibitory control prediction errors (i.e., parametric modulation by prediction error magnitude), measured as the mean BOLD signal across voxels within the region of interest (ROI). Positive values indicate that neural activation increases as signed prediction errors become more positive (i.e., stronger responses to the surprising need for control), whereas negative values indicate that activation decreases as signed prediction errors become more positive (i.e., stronger responses to the surprising lack of need for control).

    after 16 hours of fasting and at 30 minutes after a standardized meal (as least 24 hours apart, but not more than 7 days apart)

  • Brain Activation Associated With Successful Inhibition

    Frontostriatal activation associated with successful inhibition , measured as the mean BOLD signal across voxels within the region of interest (ROI) for the contrast of Successful Stop vs. Go trials. Positive values indicate activation associated with successful inhibition.

    after 16 hours of fasting and at 30 minutes after a standardized meal (as least 24 hours apart, but not more than 7 days apart)

Secondary Outcomes (2)

  • Stop Signal Reaction Time (SSRT)

    after 16 hours of fasting and at 30 minutes after a standardized meal (as least 24 hours apart, but not more than 7 days apart)

  • Stop Signal Task Inhibition

    after 16 hours of fasting and at 30 minutes after a standardized meal (as least 24 hours apart, but not more than 7 days apart)

Study Arms (2)

Participants with Bulimia Nervosa

OTHER

Participants are randomly assigned (in even numbers across the two groups) to scan order: A. These participants are first scanned after 16 hours of fasting on one day, and are next scanned after a standardized meal on a second day. B. These participants are first scanned after a standardized meal on one day, and are next scanned after 16 hours of fasting on a second day.

Other: fasting stateOther: fed stateOther: magnetic resonance imaging

Participants without Bulimia Nervosa

OTHER

Participants are randomly assigned (in even numbers across the two groups) to scan order: A. These participants are first scanned after 16 hours of fasting on one day, and are next scanned after a standardized meal on a second day. B. These participants are first scanned after a standardized meal on one day, and are next scanned after 16 hours of fasting on a second day.

Other: fasting stateOther: fed stateOther: magnetic resonance imaging

Interventions

16 hours of fasting

Participants with Bulimia NervosaParticipants without Bulimia Nervosa

fed a standardized meal

Participants with Bulimia NervosaParticipants without Bulimia Nervosa

neuroimaging with computational modeling

Also known as: MRI
Participants with Bulimia NervosaParticipants without Bulimia Nervosa

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe prevalence of bulimia nervosa is substantially greater in women than in men. Moreover, prior research suggest that men and women show different neural response patterns during the engagement of inhibitory control, and that satiety differentially impacts the neural function of men and women.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female
  • Aged 18 to 35 years
  • Currently between 85 and 130% of the expected weight for height
  • Right-handed
  • English-speaking
  • \- Meet DSM-5 criteria for bulimia nervosa

You may not qualify if:

  • Medical instability
  • Ongoing medical treatment, medical condition, or psychiatric disorder that may interfere with study variables or participation
  • Shift work
  • Pregnancy, planned pregnancy, or lactation during the study period
  • Allergy to any of the ingredients in or unwillingness to consume the standardized meal or unwillingness to drink water during the fasting period
  • Any contraindication for fMRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States

Location

MeSH Terms

Conditions

Bulimia NervosaBulimiaFastingFeeding and Eating Disorders

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Mental DisordersHyperphagiaSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Results Point of Contact

Title
Laura Berner
Organization
Icahn School of Medicine at Mount Sinai

Study Officials

  • Laura A Berner, PhD

    Department of Psychiatry, Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Two participant groups (one with and one without bulimia nervosa) will be scanned using MRI after they have fasted and after they have consumed a standardized meal. The order of these two scans will be counterbalanced across groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychiatry

Study Record Dates

First Submitted

May 18, 2020

First Posted

June 1, 2020

Study Start

September 18, 2020

Primary Completion

November 5, 2024

Study Completion

November 5, 2024

Last Updated

February 6, 2026

Results First Posted

January 14, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Shared Documents
SAP
Time Frame
Beginning 24 months following peer-reviewed article publication
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose.

Locations